Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule InhibitorGang Zhao, Philip R. Kym, Brian A. Droz et al.|Journal of Medicinal Chemistry|2008Cited by 140
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131Karen A. Gelmon, Lesley Seymour, Doug Stewart et al.|Annals of Oncology|2004Cited by 20